Leaflet BENELYTE solution for infusion


Indicated for: fluid and electrolyte replacement with carbohydrate supply

Route of administration: infusion

Substance: sodium chloride + potassium chloride + calcium chloride + magnesium chloride + sodium acetate + glucose (crystalloid electrolyte solution with glucose)

ATC: B05BB02 (Blood and blood forming organs | I.v. solutions | Solutions affecting the electrolyte balance)

Precautions:
Hyperglycemia
Hyperglycemia

This medicine may increase blood sugar.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Electrolyte disturbances
Electrolyte disturbances

This medicine may change blood electrolyte levels.

General data about BENELYTE

  • Substance: sodium chloride + potassium chloride + calcium chloride + magnesium chloride + sodium acetate + glucose
  • Date of last drug list: 01-07-2023
  • Commercial code: W69590001
  • Pharmaceutical form: solution for infusion
  • Quantity: 40
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: FRESENIUS KABI POLSKA SP. Z O.O. - POLONIA
  • Holder: FRESENIUS KABI ROMANIA S.R.L. - ROMANIA
  • Number: 15347/2024/01
  • Shelf life: 3 years

Other substances similar to sodium chloride + potassium chloride + calcium chloride + magnesium chloride + sodium acetate + glucose